Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA

INTRODUCTION: From an oncologic perspective, genetic detection is becoming a frontline clinical test, used to identify actionable alterations for targeted therapy, monitor molecular clonal tumor evolution, indicate disease progression and prognosis, and predict medication efficacy and resistance. Fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Chen, Siwen, Xue, Hui, Wang, Haoyi, Huang, Tianwei, Xie, Hongya, He, Jiang, Ke, Cai, Yu, Zhaonan, Ni, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126294/
https://www.ncbi.nlm.nih.gov/pubmed/35615557
http://dx.doi.org/10.2147/OTT.S351085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126294/
https://www.ncbi.nlm.nih.gov/pubmed/35615557
http://dx.doi.org/10.2147/OTT.S351085

Ejemplares similares